JNJ vs XPEV · P/E 17, rev $49.37B vs rev $895.7M
Johnson & Johnson (JNJ) versus Xpeng Inc (XPEV) — a side-by-side from cached financials, not a winner call.
Johnson & Johnson (JNJ) is a drug manufacturers - general company listed on US. It is led by Joaquin Duato.
Xpeng Inc (XPEV) is a auto manufacturers company listed on US. It is led by Xiaopeng He.
Latest reported JNJ revenue for 2026-06-28 was $49.37B. Net income was $10.77B. JNJ currently screens at market cap $375.37B and trailing P/E 17.4.
Latest reported XPEV revenue for 2020-12-31 was $895.7M. Net income was -$418.7M. XPEV currently screens at market cap $20.28B.
JNJ currently screens at market cap $375.37B and trailing P/E 17.4. XPEV currently screens at market cap $20.28B.
Not investment advice. Open the JNJ and XPEV stock pages for the full models.
Not investment advice.